VRDN insider buying
Every open-market purchase of Viridian Therapeutics, Inc.\DE (VRDN) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$20M
Insiders buying (12m)1
Purchases on record2
Last purchase filedMay 13, 2026
In the last 12 months, 1 insider of Viridian Therapeutics, Inc.\DE bought $20M of VRDN stock on the open market in 1 reported purchase. The most recent was filed on May 13, 2026: Fairmount Healthcare Fund II L.P. +2 (Director, 10% Owner) bought 1,176,470 shares at $17.00, worth $20M.
Get the next VRDN insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on Telegram